These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 10565920
41. Identification of reactive Borrelia burgdorferi peptides associated with Lyme disease. Tokarz R, Guo C, Sanchez-Vicente S, Horn E, Eschman A, Turk SP, Lipkin WI, Marques A. mBio; 2024 Oct 16; 15(10):e0236024. PubMed ID: 39248571 [Abstract] [Full Text] [Related]
42. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. Panelius J, Lahdenne P, Heikkilä T, Peltomaa M, Oksi J, Seppälä I. J Med Microbiol; 2002 Sep 16; 51(9):731-739. PubMed ID: 12358063 [Abstract] [Full Text] [Related]
43. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing. Bradshaw GL, Thueson RK, Uriona TJ. J Clin Microbiol; 2017 Oct 16; 55(10):3046-3056. PubMed ID: 28768731 [Abstract] [Full Text] [Related]
44. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Fung BP, McHugh GL, Leong JM, Steere AC. Infect Immun; 1994 Aug 16; 62(8):3213-21. PubMed ID: 8039891 [Abstract] [Full Text] [Related]
45. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis]. Zajkowska JM, Kondrusik M, Pancewicz SA, Grygorczuk S, Jamiołkowski J, Stalewska J. Pol Merkur Lekarski; 2007 Aug 16; 23(134):95-9. PubMed ID: 18044336 [Abstract] [Full Text] [Related]
46. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters. Lovrich SD, Jobe DA, Schell RF, Callister SM. Clin Diagn Lab Immunol; 2005 Jun 16; 12(6):746-51. PubMed ID: 15939749 [Abstract] [Full Text] [Related]
47. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area. Nyman D, Willén L, Jansson C, Carlsson SA, Granlund H, Wahlberg P. Clin Microbiol Infect; 2006 May 16; 12(5):496-7. PubMed ID: 16643532 [No Abstract] [Full Text] [Related]
48. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. Schutzer SE, Coyle PK, Krupp LB, Deng Z, Belman AL, Dattwyler R, Luft BJ. J Clin Invest; 1997 Aug 15; 100(4):763-7. PubMed ID: 9259573 [Abstract] [Full Text] [Related]
49. Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease. Gomes-Solecki MJ, Dunn JJ, Luft BJ, Castillo J, Dykhuizen DE, Yang X, Glass JD, Dattwyler RJ. J Clin Microbiol; 2000 Jul 15; 38(7):2530-5. PubMed ID: 10878038 [Abstract] [Full Text] [Related]
50. Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis. Hsieh YF, Liu HW, Hsu TC, Wei JC, Shih CM, Krause PJ, Tsay GJ. Clin Vaccine Immunol; 2007 Nov 15; 14(11):1437-41. PubMed ID: 17881508 [Abstract] [Full Text] [Related]
51. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF. Clin Vaccine Immunol; 2009 Feb 15; 16(2):253-9. PubMed ID: 19052162 [Abstract] [Full Text] [Related]
52. Detection of Lyme disease after OspA vaccine. Schutzer SE, Luan J, Coyle PK. N Engl J Med; 1997 Sep 11; 337(11):794-5. PubMed ID: 9289653 [No Abstract] [Full Text] [Related]
53. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Wilske B, Fingerle V, Herzer P, Hofmann A, Lehnert G, Peters H, Pfister HW, Preac-Mursic V, Soutschek E, Weber K. Med Microbiol Immunol; 1993 Nov 11; 182(5):255-70. PubMed ID: 8283961 [Abstract] [Full Text] [Related]
54. Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease. Arnaboldi PM, Seedarnee R, Sambir M, Callister SM, Imparato JA, Dattwyler RJ. Clin Vaccine Immunol; 2013 Apr 11; 20(4):474-81. PubMed ID: 23365204 [Abstract] [Full Text] [Related]
55. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. Callister SM, Schell RF. J Infect Dis; 1994 Aug 11; 170(2):499-500. PubMed ID: 8035047 [No Abstract] [Full Text] [Related]
56. NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies. Huang X, Yang X, Luft BJ, Koide S. J Mol Biol; 1998 Aug 07; 281(1):61-7. PubMed ID: 9680475 [Abstract] [Full Text] [Related]
57. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. Magnarelli LA, Ijdo JW, Padula SJ, Flavell RA, Fikrig E. J Clin Microbiol; 2000 May 07; 38(5):1735-9. PubMed ID: 10790090 [Abstract] [Full Text] [Related]
58. Enzyme-linked immunosorbent assays with recombinant internal flagellin fragments derived from different species of Borrelia burgdorferi sensu lato for the serodiagnosis of Lyme neuroborreliosis. Hauser U, Wilske B. Med Microbiol Immunol; 1997 Oct 07; 186(2-3):145-51. PubMed ID: 9403843 [Abstract] [Full Text] [Related]
59. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans. Tjernberg I, Sillanpää H, Seppälä I, Eliasson I, Forsberg P, Lahdenne P. Int J Med Microbiol; 2009 Aug 07; 299(6):439-46. PubMed ID: 19138558 [Abstract] [Full Text] [Related]
60. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre. Zwerink M, Zomer TP, van Kooten B, Blaauw G, van Bemmel T, van Hees BC, Vermeeren YM, Landman GW. Ticks Tick Borne Dis; 2018 Mar 07; 9(3):594-597. PubMed ID: 29422448 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]